<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1261">
  <stage>Registered</stage>
  <submitdate>4/05/2006</submitdate>
  <approvaldate>4/05/2006</approvaldate>
  <actrnumber>ACTRN12606000159550</actrnumber>
  <trial_identification>
    <studytitle>The feasibility of Continuous Positive Airway Pressure (CPAP) treatment for sleep disordered breathing in acute tetraplegia</studytitle>
    <scientifictitle>The feasibility of Continuous Positive Airway Pressure (CPAP) treatment for sleep disordered breathing in acute tetraplegia</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Obstructive Sleep Apnoea (OSA) in acute tetraplegia</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other injuries and accidents</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Three months trial of Continuous Positive Airway Pressure (CPAP) treatment for OSA in tetraplegia</interventions>
    <comparator>No comparator.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Effectiveness of change in oxygen desaturation rate</outcome>
      <timepoint>Measurements of effectiveness will be made at baseline and after 3 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Adherence to therapy</outcome>
      <timepoint>Adherence will be monitored daily and recorded weekly</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The amount and nature of the assistance required to maximise CPAP uptake will be examined to determine what proportion of subjects required what amount of support. </outcome>
      <timepoint>These measures will be made daily and recorded weekly.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Acute tetraplegia. All American Spinal Injury Association (ASIA) classifications and lesion levels will be included.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Admission, physician diagnosis of significant head injury, significant pre-existing respiratory or cardiac disease and any other significant co-morbidity. An inability of provide informed consent. Planned hospital discharge within six weeks.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/06/2006</anticipatedstartdate>
    <actualstartdate>1/01/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate>1/10/2007</actualenddate>
    <samplesize>18</samplesize>
    <actualsamplesize>19</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Institute for breathing and sleep</primarysponsorname>
    <primarysponsoraddress>Institute for Breathing and Sleep Austin Hospital Studley Rd Heidelberg VIC 3084</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Institute for breathing and sleep</fundingname>
      <fundingaddress>Institute for Breathing and Sleep Austin Hospital Studley Rd Heidelberg VIC 3084</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is designed to examine the feasibility of Continuous Positive Airway Pressure (CPAP) treatment for Obstructive Sleep Apnoea (OSA) in acute tetraplegia. This pilot study will examine how well CPAP is tolerated and if treatment is feasible prior to the commencement of any randomised, controlled trial of therapy.</summary>
    <trialwebsite />
    <publication>Berlowitz DJ, Spong J, Pierce RJ, Ross J, Barnes M &amp; Brown DJ. The feasibility of using auto-titrating continuous positive airway pressure to treat obstructive sleep apnoea after acute tetraplegia. Spinal Cord 2009 47: 868-873. </publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Austin Heath Human Ethics</ethicname>
      <ethicaddress>Austin Health
Studley Rd
Heidelberg 3084
Vic</ethicaddress>
      <ethicapprovaldate>13/04/2006</ethicapprovaldate>
      <hrec>H2006/02543</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>David Berlowitz</name>
      <address>Institute for Breathing and Sleep
Austin Hospital 
Studley Rd Heidelberg VIC 3084</address>
      <phone>+61 3 94963688</phone>
      <fax />
      <email>david.berlowitz@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>David Berlowitz</name>
      <address>Institute for Breathing and Sleep
Austin Hospital 
Studley Rd Heidelberg VIC 3084</address>
      <phone>+61 3 94963688</phone>
      <fax />
      <email>david.berlowitz@austin.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>David Berlowitz</name>
      <address>Bowen Centre. Austin Health
Studley Rd Heidelberg 3084
Vic</address>
      <phone>+61394963871</phone>
      <fax />
      <email>david.berlowitz@austin.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>